Pacer Advisors
ROIV icon

Pacer Advisors’s Roivant Sciences ROIV Stock Holding History

Pacer Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
72,024
-24,279
-25% -$717K 0.01% 914
2026
Q1 		$2.67M Buy
96,303
+26,044
+37% +$669K 0.01% 821
2025
Q4 		$1.52M Buy
70,259
+13,609
+24% +$268K ﹤0.01% 1241
2025
Q3 		$857K Buy
+56,650
New +$701K ﹤0.01% 1517
2025
Q1 		– Sell
-64,022
Closed -$757K – 3764
2024
Q4 		$757K Buy
64,022
+302
+0.5% +$3.57K ﹤0.01% 1470
2024
Q3 		$735K Buy
63,720
+8,220
+15% +$93.6K ﹤0.01% 1500
2024
Q2 		$587K Buy
55,500
+51,501
+1,288% +$564K ﹤0.01% 1533
2024
Q1 		$42.1K Buy
+3,999
New +$43.1K ﹤0.01% 3237

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Pacer Advisors's ROIV Position: Q2 2026 in Review

Pacer Advisors reduced its Roivant Sciences (ROIV) stake by 25% in Q2 2026, selling an estimated $717K and leaving 72,024 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #914.

Pacer Advisors first reported a position in ROIV in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.67M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Pacer Advisors held 72,024 shares of Roivant Sciences worth $2.55M as of Q2 2026.
  • Pacer Advisors sold 24,279 Roivant Sciences shares in Q2 2026, an estimated $717K.
  • Roivant Sciences made up 0.01% of Pacer Advisors's portfolio in Q2 2026, its #914 holding.
  • Pacer Advisors first reported a position in Roivant Sciences in Q1 2024 and has held it in 8 quarters since.
  • Pacer Advisors's Roivant Sciences position peaked at $2.67M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.